MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy - Implications for induction chemotherapy?

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 3, 2013, Pages 505-511

  Yu, Stanley K T ^a   Tait, Diana ^a   Chau, Ian ^b   Brown, Gina ^c  

^a Great Ormond Street Hosp Children   (United Kingdom)

^b NONE   (United Kingdom)

^c Academic Department of Radiology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIATION THERAPIES; INDEPENDENT PREDICTORS; INDUCTION CHEMOTHERAPY; LOCALLY ADVANCED RECTAL CANCERS; MULTIVARIATE LOGISTIC REGRESSIONS; NEOADJUVANT CHEMORADIATION; NEOADJUVANT TREATMENT; POSITIVE PREDICTIVE VALUES;

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASES; PATHOLOGY; TUMORS;

MAGNETIC RESONANCE IMAGING;

CAPECITABINE; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; CANCER STAGING; CLINICAL ASSESSMENT; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT DURATION; TUMOR VOLUME;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84884881217     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.06.2052     Document Type: Article

References (38)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
3. N.A. Janjan, C. Crane, and B.W. Feig Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer Am J Clin Oncol 24 2001 107 112
4. A.K. Chan, A. Wong, and D. Jenken Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 61 2005 665 677
5. L.J. Kuo, M.C. Liu, and J.J. Jian Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14 2007 2766 2772
6. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674
7. A. Rullier, C. Laurent, and M. Capdepont Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma Am J Surg Pathol 34 2010 562 568
8. U.B. Patel, F. Taylor, and L. Blomqvist Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience J Clin Oncol 29 2011 2753 2760
9. N.A. Janjan, V.S. Khoo, and J. Abbruzzese Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The M.D. Anderson Cancer Center experience Int J Radiat Oncol Biol Phys 44 1999 1027 1038
10. P. Das, J.M. Skibber, and M.A. Rodriguez-Bigas Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Cancer 109 2007 1750 1755
11. R. Ferrigno, P.E. Novaes, and M.L. Silva Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors Radiat Oncol 1 2006 5
12. J.H. Jeong, S.Y. Jung, and I.H. Park Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer Invest New Drugs 30 2012 408 416
13. G. Brown, A.G. Radcliffe, and R.G. Newcombe Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging Br J Surg 90 2003 355 364
14. D.M. Lambregts, G.L. Beets, and M. Maas Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer Ann Surg 253 2011 539 545
15. MERCURY Study Group Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study BMJ 333 2006 779
16. G. Salerno, I. Chandler, and A. Wotherspoon Sites of surgical wasting in the abdominoperineal specimen Br J Surg 95 2008 1147 1154
17. O.C. Shihab, F. Taylor, and G. Salerno MRI predictive factors for long-term outcomes of low rectal tumours Ann Surg Oncol 18 2011 3278 3284
18. A. Dewdney, D. Cunningham, and J. Tabernero Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) J Clin Oncol 30 2012 1620 1627
19. L. Sobin, and C. Wittekind TNM Classification of Malignant Tumours 5th ed 1997 John Wiley & Sons New York
20. Williams GT, Quirke P, Shepherd NA. Dataset for colorectal cancer. In Standards and Datasets for Reporting Cancers. 2nd ed. Dataset for colorectal cancer on behalf of the RCPath Cancer Services Working Group. Available at: http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/ G049-ColorectalDataset-Sep07.pdf. Accessed January 8, 2012.
21. B. Barbaro, C. Fiorucci, and C. Tebala Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy Radiology 250 2009 730 739
22. R.C. Dresen, G.L. Beets, and H.J. Rutten Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252 2009 71 80
23. M.F. Kalady, L.F. de Campos-Lobato, and L. Stocchi Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg 250 2009 582 589
24. A. Habr-Gama, R.O. Perez, and W. Nadalin Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results Ann Surg 240 2004 711 717 discussion 717-718
25. A. Habr-Gama, R.O. Perez, and I. Proscurshim Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: Does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 71 2008 1181 1188
26. M. Maas, R.G. Beets-Tan, and D.M. Lambregts Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
27. B. O'Neill, G. Brown, and A. Wotherspoon Successful downstaging of high rectal and recto-sigmoid cancer by neo-adjuvant chemo-radiotherapy Clin Med Oncol 2 2008 135
28. I.C. Talbot, S. Ritchie, and M.H. Leighton The clinical significance of invasion of veins by rectal cancer Br J Surg 67 1980 439 442
29. K. Shirouzu, H. Isomoto, and T. Kakegawa A prospective clinicopathologic study of venous invasion in colorectal cancer Am J Surg 162 1991 216 222
30. E.L. Bokey, P.H. Chapuis, and O.F. Dent Factors affecting survival after excision of the rectum for cancer: a multivariate analysis Dis Colon Rectum 40 1997 3 10
31. R.C. Dresen, E.E. Peters, and H.J. Rutten Local recurrence in rectal cancer can be predicted by histopathological factors Eur J Surg Oncol 35 2009 1071 1077
32. K. Ouchi, T. Sugawara, and H. Ono Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis Cancer 78 1996 2313 2317
33. A. Horn, O. Dahl, and I. Morild The role of venous and neural invasion on survival in rectal adenocarcinoma Dis Colon Rectum 33 1990 598 601
34. M.J. Krasna, L. Flancbaum, and R.P. Cody Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance Cancer 61 1988 1018 1023
35. N.J. Smith, Y. Barbachano, and A.R. Norman Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer Br J Surg 95 2008 229 236
36. I. Chau, G. Brown, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer J Clin Oncol 24 2006 668 674
37. Y.J. Chua, Y. Barbachano, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial Lancet Oncol 11 2010 241 248
38. F.M. Vecchio, V. Valentini, and B.D. Minsky The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760